Rachel Montgomery - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Rachel Montgomery's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Rachel Montgomery
Verified
Contributor, BioNews
London
Beats
Technology, Electronics, Sports
Content
By Hannah Flynn Verified, Rachel Montgomery| PET@ UK politicians have requested an investigation into the Chinese maker of a prenatal genetic test, citing concerns related to its use of genomic data collected in the UK. BGI Group is China's leading genomics company, and its non-invasive prenatal test 'NIFTY' is used across 52 countries to screen for genetic abnormalities in fetuses by examining fetal DNA in the mother's blood. It is not used by the NHS, but is sold privately in the UK, according to the Daily Mail.
By Paige Mumford, Emma Green, Rachel Montgomery, Helen Robertson| bionews.org.uk@ 'Elite sleeper' genes may offer protection from neurodegenerative diseases21 March 2022 Appeared in BioNews 1137Genetic mutations that cause shorter sleeping times have been shown to reduce neuropathology in mouse models of Alzheimer's disease (AD), indicating that more efficient sleep may protect against neurodegenerative diseases. The quality and length of sleep is important for protecting against cognitive decline.
By Hannah Flynn Verified, Rachel Montgomery| PET@ UK politicians have requested an investigation into the Chinese maker of a prenatal genetic test, citing concerns related to its use of genomic data collected in the UK. BGI Group is China's leading genomics company, and its non-invasive prenatal test 'NIFTY' is used across 52 countries to screen for genetic abnormalities in fetuses by examining fetal DNA in the mother's blood. It is not used by the NHS, but is sold privately in the UK, according to the Daily Mail.
Company Info
BioNews
Bionews, Inc. is a digital health solutions company based in Delaware, founded in 2013. It specializes in supporting rare disease communities through over 68 health media websites, which serve more than 500,000 registered members. The company is committed to authenticity, with over half of its team having personal experience with rare diseases as patients or caregivers. Bionews connects patients, caregivers, and healthcare stakeholders by providing trusted news, clinical updates, and community resources. Its services include digital media platforms that offer condition-specific content, community engagement through forums and advocacy resources, and content development featuring articles, podcasts, and videos. The company also tracks user engagement and provides analytics to support client campaigns. Bionews collaborates with biotech, life sciences, and healthcare companies to enhance marketing and patient engagement in the rare disease sector.
'+1 800-936-1363
Founded: 2013